We report the results of a double-blind, randomized prospective trial on D2 and 5-HT2 receptor occupancy and the clinical effects of olanzapine versus clozapine in a sample of neuroleptic-refractory schizophrenic patients. Receptor occupancy was evaluated in different cortical areas and in basal ganglia using [18F] fluoro-ethyl-spiperone ([18F] FESP) and positron emission tomography (PET). A total of 15 neuroleptic-free patients completed the study undergoing a baseline and a post-treatment PET scan (olanzapine, nine patients, one female; clozapine, six patients, three female) 8 weeks after starting treatment. PET data were analysed both by regions of interest and on a voxel-by-voxel basis using Statistical Parametric Mapping (SPM96). Olanzapine and clozapine induced a similar and significant inhibition of [18F] FESP binding index in the cortex. In the basal ganglia, receptor occupancy was significantly higher with olanzapine than with clozapine (p = 0.0018). By contrast, no differences in receptor occupancy were detected at the level of the pituitary gland. Clinical outcomes, in particular a full extra pyramidaltolerability, were similar. In this sample of neuroleptic-refractoryschizophrenic patients, olanzapine and clozapine showed a differentpattern of occupancy of D2-like receptor despite a common lack of extrapyramidal side-effects.
Barnes N M , Sharp T (1999) A review of central 5-HT receptors and their function . Neuropharmacology38: 1083–1152
2.
Barrio J R , Satyamurthy N , Huang S C , Keen R E , Nissenson C H , Hoffman J M , Ackermann R F , Bahn M M , Mazziotta J C , Phelps M E (1989) 3-(2'-[18F] fluoroethyl)spiperone: in vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans . J Cereb Blood Flow Metab9: 830–839
3.
Bleich A , Brown S L , Kahn R , van Praag H M (1988) The role of serotonin in schizophrenia . Schizophr Bull14: 297–315
4.
Breier A (1995) Serotonin, schizophrenia and antipsychotic drug action . Schizophr Res14: 187–202
5.
Bressan R A , Jones H M , Ell P J , Pilowsky L S (2001) Dopamine D (2) receptor blockade in schizophrenia . Am J Psychiatry158: 971–972
6.
Bymaster F , Perry K W , Nelson D L , Wong D T , Rasmussen K , Moore N A , Calligaro D O (1999) Olanzapine: a basic science update . Br J Psychiatry37 (Suppl): 36–40
7.
Carlsson A , Waters N , Carlsson M L (1999) Neurotransmitter interactions in schizophrenia-therapeutic implications . Eur Arch Psychiatry Clin Neurosci249 (Suppl 4): 37–43
8.
Coenen H H , Wienhard K , Stocklin G , Laufer P , Hebold I , Pawlik G , Heiss WD (1988) PET measurement of D2 and S2 receptor binding of 3-N-[(2á-18F] fluoroethyl)spiperone in baboon brain . Eur J Nucl Med14: 80–87
9.
Crawford A M , Beasley C M Jr , Tollefson G D (1997) The acute and longterm effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrations . Schizophr Res26: 41–54
10.
de Haan L , van Bruggen M , Lavalaye J , Booij J , Dingemans PM , Linszen D (2003) Subjective experience and D2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study . Am J Psychiatry160: 303–309
11.
Eichhammer P , Albus M , Borrmann-Hassenbach M , Schoeler A , Putzhammer A , Frick U , Klein H E , Rohrmeier T (2000) Association of dopamine D3-receptor gene variants with neuroleptic induced akathisia in schizophrenic patients: a generalization of Steen’s study on DRD3 and tardive dyskinesia . Am J Med Genet96: 187–191
12.
Farde L , Nordstrom A L , Wiesel F A , Pauli S , Halldin C , Sedvall G (1992) Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects . Arch Gen Psychiatry49: 538–544
13.
Fleischhacker W W , Hummer M , Kurz M , Kurzthaler I , Lieberman J A , Pollack S , Safferman A Z , Kane J M (1994) Clozapine dose in the United States and Europe: implications for therapeutic and adverse effects . J Clin Psychiatry55 (Suppl B): 78–81
14.
Friston K J , Frith C D , Liddle P F , Frackowiak R S (1991) Comparing functional (PET) images: the assessment of significant change . J Cereb Blood Flow Metab11: 690–699
15.
Frost J J , Smith A C , Kuhar M J , Dannals R F , Wagner H N Jr (1987) In vivo binding of 3H-N-methylspiperone to dopamine and serotonin receptors . Life Sci40: 987–995
16.
Gerlach J , Peacock L (1995) New antipsychotics: the present status . Int Clin Psychopharmacol10 (Suppl 3): 39–48
17.
Goffinet A M , Leysen J , Labar D (1990) In vitro pharmacological profile of 3-N-(2-fluoroethyl)spiperone . J Cereb Blood Flow Metab10: 140–142
18.
Goyer P F , Berridge M S , Morris E D , Semple W E , Compton-Toth B A , Schulz S C , Wong D F , Miraldi F , Meltzer H Y (1996) PET measurement of neuroreceptor occupancy by typical and atypical neuroleptics . J Nucl Med37: 1122–1127
19.
Hagberg G , Gefvert O , Bergstrom M , Wieselgren I M , Lindstrom L , Wiesel F A , Langstrom B (1998) N-[11C] methylspiperone PET, in contrast to [11C] raclopride, fails to detect D2 receptor occupancy by an atypical neuroleptic . Psychiatry Res82: 147–160
20.
Hall H , Farde L , Halldin C , Hurd Y L , Pauli S , Sedvall G (1996) Autoradiographic localization of extrastriatal D2-dopamine receptors in the human brain using [125I] epidepride . Synapse23: 115–123
21.
Ito H , Nyberg S , Halldin C , Lundkvist C , Farde L (1998) PET imaging of central 5-HT2A receptors with carbon-11-MDL 100 907 . J Nucl Med39: 208–214
22.
Jovkar S , Wienhard K , Coenen H H , Pawlik G , Heiss W D (1991) Quantification of baboon cortical S2 serotonin receptors in vivo with 3-N-(2'-F18)fluoroethylspiperone and positron emission tomography . Eur J Nucl Med18: 158–163
23.
Joyce J N , Gurevich E V (1999) D3 receptors and the actions of neuroleptics in the ventral striatopallidal system of schizophrenics . Ann NY Acad Sci877: 595–613
24.
Kapur S (1996) 5-HT2 antagonism and EPS benefits: is there a causalconnection?Psychopharmacology (Berl)124: 35–39
25.
Kapur S , Seeman P (2001) Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics? A new hypothesis . Am J Psychiatry158: 360–369
26.
Kapur S , Zipursky R B , Remington G , Jones C , DaSilva J , Wilson A A , Houle S (1998) 5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation . Am J Psychiatry155: 921–928
27.
Kapur S , Zipursky R B , Remington G (1999) Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia . Am J Psychiatry156: 286–293
28.
Kapur S , Zipursky R , Jones C , Remington G , Houle S (2000) Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia . Am J Psychiatry157: 514–520
29.
Kasper S , Jones M , Duchesne I (2001) Risperidone olanzapine drug outcomes studies in schizophrenia (RODOS): health economic results of an international naturalistic study . Int Clin Psychopharmacol16: 189–196
30.
Kiebel S J , Poline J B , Friston K J , Holmes A P , Worsley K J (1999) Robust smoothness estimation in statistical parametric maps using standardized residuals from the general linear model . Neuroimage10: 756–766
31.
Lerer B , Segman R H , Fangerau H , Daly A K , Basile V S , Cavallaro R , Aschauer H N , McCreadie R G , Ohlraun S , Ferrier N , Masellis M , Verga M , Scharfetter J , Rietschel M , Lovlie R , Levy U H , Meltzer H Y , Kennedy J L , Steen V M , Macciardi F (2002) Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism . Neuropsychopharmacology27: 105–119
32.
Markianos M , Hatzimanolis J , Lykouras L (1999) Switch from neuroleptics to clozapine does not influence pituitary-gonadal axis hormone levels in male schizophrenic patients . Eur Neuropsychopharmacol9: 533–536
33.
Meisenzahl E M , Dresel S , Frodl T , Schmitt G J , Preuss U W , Rossmuller B , Tatsch K , Mager T , Hahn K , Moller H J (2000) D2 receptor occupancy under recommended and high doses of olanzapine: an iodine-123-iodobenzamide SPECT study . J Psychopharmacol14: 364–370
34.
Meltzer H Y (1999) The role of serotonin in antipsychotic drug action . Neuropsychopharmacology21: 106S–1115S
35.
Meltzer H Y , Matsubara S , Lee J C (1989) Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values . J Pharmacol Exp Ther251: 238–246
36.
Mengod G , Villaro M T , Landwehrmeyer G B , Martinez-Mir M I , Niznik H B , Sunahara R K , Seeman P , O’Dowd B F , Probst A , Palacios J M (1992) Visualization of dopamine D1, D2 and D3 receptor mRNAs in human and rat brain. Neurochem Int 20 Suppl: 33S-43S
37.
Moresco R M , Colombo C , Fazio F , Bonfanti A , Lucignani G , Messa C , Gobbo C , Galli L , Del Sole A , Lucca A , Smeraldi E (2000) Effects of fluvoxamine treatment on the in vivo binding of [F-18] FESP in drug naive depressed patients: a PET study . Neuroimage12: 452–465
38.
Nordstrom A L , Farde L , Wiesel F A , Forslund K , Pauli S , Halldin C , Uppfeldt G (1993) Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients . Biol Psychiatry33: 227–235
39.
Nordstrom A L , Farde L , Nyberg S , Karlsson P , Halldin C , Sedvall G (1995) D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients . Am J Psychiatry152: 1444–1449
40.
Nordstrom A L , Nyberg S , Olsson H , Farde L (1998) Positron emission tomography finding of a high striatal D2 receptor occupancy inolanzapine-treated patients . Arch Gen Psychiatry55: 283–284
41.
Nyberg S , Eriksson B , Oxenstierna G , Halldin C , Farde L (1999) Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patients . Am J Psychiatry156: 869–875
42.
Ozdemir V , Kalow W , Okey A B , Lam M S , Albers L J , Reist C , Fourie J , Posner P , Collins E J , Roy R (2001) Treatment-resistance to clozapine in association with ultrarapid CYP1A2 activity and the C–>A polymorphism in intron 1 of the CYP1A2 gene: effect of grapefruit juice and low-dose fluvoxamine . J Clin Psychopharmacol21: 603–607
43.
Pietrzyk U , Herholz K , Fink G , Jacobs A , Mielke R , Slansky I , Wurker M , Heiss W D (1994) An interactive technique for three-dimensional image registration: validation for PET, SPECT, MRI and CT brain studies . J Nucl Med 35: 2011–2018
44.
Piggott M A , Marshall E F , Thomas N , Lloyd S , Court J A , Jaros E , Costa D , Perry R H , Perry E K (1999) Dopaminergic activities in the human striatum: rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine . Neuroscience90: 433–445
45.
Pilowsky L S (2001) Probing targets for antipsychotic drug action with PET and SPET receptor imaging . Nucl Med Commun22: 829–833
46.
Pirker W , Riedl M , Luger A , Czech T , Rossler K , Asenbaum S , Angelberger P , Kornhuber J , Deecke L , Podreka I , Brucke T (1996) Dopamine D2 receptor imaging in pituitary adenomas using iodine-123-epidepride and SPECT . J Nucl Med 37: 1931–1937
47.
Remington G , Kapur S (1999) D2 and 5-HT2 receptor effects of anti-psychotics: bridging basic and clinical findings using PET . J Clin Psychiatry60 (Suppl 10): 15–19
48.
Schmitt G J , Meisenzahl E M , Dresel S , Tatsch K , Rossmuller B , Frodl T , Preuss U W , Hahn K , Moller H J (2002) Striatal dopamine D2 receptor binding of risperidone in schizophrenic patients as assessed by 123I-iodobenzamide SPECT: a comparative study with olanzapine . J Psychopharmacol16: 200–206
49.
Seeman P , Tallerico T (1998) Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors . Mol Psychiatry3: 123–134
50.
Seeman P , Van Tol H H (1995) Deriving the therapeutic concentrations for clozapine and haloperidol: the apparent dissociation constant of a neuroleptic at the dopamine D2 or D4 receptor varies with the affinity of the competing radioligand . Eur J Pharmacol291: 59–66
51.
Silvestri S , Seeman M V , Negrete J C , Houle S , Shammi C M , Remington G J , Kapur S , Zipursky R B , Wilson A A , Christensen B K , Seeman P (2000) Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study . Psychopharmacology (Berl)152: 174–180
52.
Stockmeier C A , DiCarlo J J , Zhang Y , Thompson P , Meltzer H Y (1993) Characterization of typical and atypical antipsychotic drugs based on in vivo occupancy of serotonin2 and dopamine2 receptors . J Pharmacol Exp Ther266: 1374–1384
53.
Talairach J , Tournoux P (1988) A co-planar stereotactic atlas of the human brain. Thieme, Thieme
54.
Talvik M , Nordstrom A L , Nyberg S , Olsson H , Halldin C , Farde L (2001) No support for regional selectivity in clozapine-treated patients: a PET study with [(11)C] raclopride and [(11)C] FLB 457 . Am J Psychiatry158: 926–930
55.
Tauscher J , Kufferle B , Asenbaum S , Fischer P , Pezawas L , Barnas C , Tauscher-Wisniewski S , Brucke T , Kasper S (1999) In vivo 123I IBZM SPECT imaging of striatal dopamine-2 receptor occupancy in schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol . Psychopharmacology (Berl)141: 175–181
56.
Tauscher J , Kapur S , Verhoeff N P , Hussey D F , Daskalakis Z J , Tauscher-Wisniewski S , Wilson A A , Houle S , Kasper S , Zipursky R B (2002) Brain serotonin 5-HT (1A) receptor binding in schizophrenia measured by positron emission tomography and [11C] WAY-100635 . Arch Gen Psychiatry59: 514–520
57.
Turrone P , Kapur S , Seeman M V , Flint A J (2002) Elevation of prolactin levels by atypical antipsychotics . Am J Psychiatry159: 133–135
58.
van Veelen N M , Kahn R S (1999) Dopamine, serotonin, and schizophrenia . Adv Neurol80: 425–429
59.
Westerink B H (2002) Can antipsychotic drugs be classified by their effects on a particular group of dopamine neurons in the brain?Eur J Pharmacol455: 1–18
60.
Wienhard K , Coenen H H , Pawlik G , Rudolf J , Laufer P , Jovkar S , Stocklin G , Heiss W D (1990) PET studies of dopamine receptor distribution using [18F] fluoroethyl spiperone: findings in disorders related to the dopaminergic system . J Neural Transm Gen Sect81: 195–213
61.
Woods R P , Cherry S R , Mazziotta J C (1992) Rapid automated algorithm for aligning and reslicing PET images . J Comput Assist Tomogr16: 620–633
62.
Worsley K J , Evans A C , Marrett S , Neelin P (1992) A three-dimensional statistical analysis for CBF activation studies in human brain . J Cereb Blood Flow Metab12: 900–918
63.
Xiberas X , Martinot J L , Mallet L , Artiges E , Loc H C , Maziere B , Paillere-Martinot M L (2001) Extrastriatal and striatal D (2) dopamine receptor blockade with haloperidol or new antipsychotic drugs in patients with schizophrenia . Br J Psychiatry179: 503–508
